Hend El-sherbini Leads Idh To 111 Million Revenue In 2024

Integrated Diagnostics Holdings IDH reports a 39 revenue increase to 111.9 million in 2024, driven by higher test volumes.

Profits soared 115 to EGP1.01 billion 19.72 million, boosted by foreign exchange gains and reduced net interest expenses.

IDH operates 628 laboratories across Egypt, Jordan, Sudan, and Nigeria, maintaining strong growth despite regional economic challenges.

Integrated Diagnostics Holdings IDH, a leading healthcare services provider based in Cairo and headed by Egyptian businesswoman Hend El-Sherbini, posted impressive financial results for 2024, with revenue surpassing 110 million.

This growth, driven by an increase in test volumes, patient numbers, and higher revenue per test, highlights the company's strong performance in the face of broader economic challenges.

According to its latest report , IDHs revenue rose to EGP5.72 billion 111.88 million in 2024, up from EGP4.12 billion 80.64 million the previous yearan increase of 39 percent.

A 5 percent uptick in patient numbers helped lift profits, which jumped by 115 percent to EGP1.01 billion 19.72 million. This was largely due to foreign exchange gains totaling EGP303 million and a 41 percent drop in net interest expenses, both of which strengthened the companys bottom line.

Egypt remains at the heart of IDHs business, contributing EGP4.72 billion 92.28 million, or 82.5 percent of the groups total revenue. In Jordan, the Biolab unit brought in JOD13.9 million 19.61 million, accounting for nearly 16 percent of overall earnings.